Michael A. Diefenbach

Michael A. Diefenbach

Auto-generated profile, based on publicly available information

Michael A. Diefenbach

Northwell Urology, Department of Urology, Zucker School of Medicine, Northwell Health, New Hyde Park, USA; Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, New Hyde Park, USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
AMAllison Marziliano
Allison Marziliano
STSewit Teckie
Sewit Teckie
MDMichael A. Diefenbach
Michael A. Diefenbach


19 March 2021 in JMIR Formative Research
Verified
Journal Article
Open access
STSewit Teckie
Sewit Teckie
JSJeffrey Solomon
Jeffrey Solomon
KKKarthik Kadapa
Karthik Kadapa
KSKeisy Sanchez
Keisy Sanchez
DODavid Orner
David Orner
MDMichael Diefenbach
Michael Diefenbach
Background: Patients with head and neck cancer (HNC) frequently experience disease-related symptoms and treatment adverse effects that impact their overall quality of life. Cancer-specific mobile health apps for patient-related outcomes allow patients to communicate with their clinicians and proactively track their symptoms, which have been shown to improve clinical management and disease outcomes. Objective: The purpose of this study was to evaluate the feasibility of LogPAL, a novel iPhone-based mobile health app designed to help HNC survivors track and manage their posttreatment symptoms. Methods: Patients who completed curative treatment for HNC in the preceding 24 months were recruited from 2 clinical sites within a single institution. Upon enrollment, participants completed a brief sociodemographic survey, downloaded the app onto their iPhone devices, and were asked to complete a series of biweekly questionnaires (based on the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events) via the app for an 8-week study period. The primary feasibility endpoints included retention (retaining >80% of the enrolled participants for the duration of the study period), adherence (>50% of the participants completing 100% of the questionnaires over the study period), and usability (a mean system usability scale [SUS] score >68). Additional postintervention questions were collected to assess perceived usefulness, acceptance, and overall satisfaction. Results: Between January and October 2019, 38 participants were enrolled in the study. Three participants dropped out, and 3 were classified as nonusers. The remaining 32 (87%) were eligible for analysis. Their mean age was 57.8 (SD 12.3) years (range 24-77 years, 81% [26/32] male). Overall, 375 of 512 (73.2%) questionnaires were completed, with 17 (53%) of the 32 participants adherent. Participant-reported usability was acceptable; the mean SUS score was 71.9 (95% CI 64.3-79.5) with high satisfaction of LogPAL usefulness and likelihood to recommend to other cancer survivors. Conclusions: This single-arm prospective pilot study showed that LogPAL is a feasible, regularly used, accepted app for HNC survivors, justifying a full-scale pilot. Based on the findings from this study, future iterations will aim to improve usability and test intervention efficacy.

2 July 2018 in Translational Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
MDMichael A Diefenbach
Michael A Diefenbach
CBCatherine Benedict
Catherine Benedict
SMSuzanne M Miller
Suzanne M Miller
ASAnnette L Stanton
Annette L Stanton
MRMary E Ropka
Mary E Ropka
SHSimon J Hall
Simon J Hall
Men diagnosed with early stage prostate cancer face multiple treatment options, each with distinctive side effects that have significant implications for post-treatment quality of life. Healing Choices for Men with Prostate Cancer is a multimedia educational and decision aid program. This nation-wide randomized controlled trial evaluated the impact of Healing Choices on reducing decisional conflict and distress. Eligible prostate cancer patients who called the National Cancer Institute's Cancer Information Service (CIS) were invited to participate. After a baseline interview, participants were randomized to usual personalized consultation with a CIS specialist (comparison condition) or CIS personalized consultation plus the Healing Choices program (intervention condition). The Decision Conflict Scale and Impact of Event Scale assessed decisional conflict about prostate cancer treatment and cancer-related distress, respectively. Analyses evaluated group differences at 2 months postenrollment. Hypothesized moderation of intervention effects by demographic and clinical characteristics were evaluated. The final sample consisted of N = 349 participants (intervention: n = 181; comparison n = 168). Men were on average 64 years old, primarily White, and well educated. The difference in total decisional conflict was not significant (DCS total score; F[1,311] = .99, p = .32). The difference in cancer-related distress at 2 months between the intervention and the comparison groups was not significant (F[1,337] = .01, p = .93). Evaluation of specific decision processes indicated a significant effect on levels of perceived decisional support (intervention, M = 34.8, SD = 15.7; comparison, M = 38.3, SD = 16.1; F[1,337] = 3.74, p = .05). The intervention effect was greatest for nonwhite minority participants (b = −9.65, SE = 4.67) and those with lower educational attainment (b = 3.87, SE = 2.21). This interactive, comprehensive education and decision aid program may be most effective for a subset of prostate cancer patients in need of educational and decisional support.

1 March 1997 in Health Education Research
Verified
Journal Article
Open access
PDF file
NWNeil D. Weinstein
Neil D. Weinstein
MDMichael A. Diefenbach
Michael A. Diefenbach
Perceptions of personal risk (i.e. risk likelihood) occupy a central role in theories of individual health behavior. There is no agreement, however, concerning the best approach for measuring these perceptions. We compared a percentage scale with a seven-point, verbally labeled scale. Data from college student subjects (N = 215) showed that the correlations between risk factors and risk likelihood judgements for seven health problems were no stronger with one scale than the other. Suggestions for when to use each scale are given.

5 August 2019 in Psycho-Oncology
Verified
Journal Article
Closed access
PDF file
CLCorinne R. Leach
Corinne R. Leach
MDMichael A. Diefenbach
Michael A. Diefenbach
SFSara Fleszar
Sara Fleszar
CACatherine M. Alfano
Catherine M. Alfano
RSRobert L. Stephens
Robert L. Stephens
SHShawna Hudson
Shawna Hudson